World's Best Scientists 2026 revealed!
Dana J. Philpott

Dana J. Philpott

Award Badge
Immunology
Canada
2026

D-Index & Metrics

Immunology

D-Index
100
Citations
41625
World Ranking
721
National Ranking
10

Dana J. Philpott publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Dana J. Philpott sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 304 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Dana J. Philpott D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Dana J. Philpott sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 100 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Canada Leader Award
  • 2025 - Research.com Immunology in Canada Leader Award

Overview

Dana J. Philpott is affiliated with the University of Toronto in Canada and has made contributions primarily in the fields of Biochemistry, Genetics and Molecular Biology, Medicine, and Immunology and Microbiology. Their research strongly focuses on Immunology, Molecular Biology, Genetics, Epidemiology, and Surgery as key subfields.

Their work addresses several main topics including:

  • Gut microbiota and health
  • Immune Cell Function and Interaction
  • Autophagy in Disease and Therapy
  • IL-33, ST2, and ILC Pathways
  • Inflammasome and immune disorders
  • Inflammatory Bowel Disease
  • Immune cells in cancer

Notable recent publications by Dana J. Philpott include:

  • "Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity," 2022, Immunity
  • "How autophagy controls the intestinal epithelial barrier," 2021, Autophagy
  • "Mitophagy pathways in health and disease," 2020, The Journal of Cell Biology
  • "The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease," 2024, Science Signaling
  • "Nod1 promotes colorectal carcinogenesis by regulating the immunosuppressive functions of tumor-infiltrating myeloid cells," 2021, Cell Reports

Dana J. Philpott frequently publishes in several scientific journals, including:

  • Journal of the Canadian Association of Gastroenterology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Immunology
  • Immunity
  • Nature Communications

Collaboration has been an aspect of their scientific activity, with numerous coauthors including:

  • Stephen E. Girardin
  • Elisabeth G. Foerster
  • Nathaniel J. Winsor
  • Tapas Mukherjee
  • Giuliano Bayer

Best Publications

  • Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

    Stephen E. Girardin;Ivo G. Boneca;Jérôme Viala;Mathias Chamaillard

  • Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan

    Stephen E Girardin;Ivo G Boneca;Leticia A M Carneiro;Aude Antignac

  • Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry

    Leonardo H Travassos;Leticia A M Carneiro;Mahendrasingh Ramjeet;Seamus Hussey;Seamus Hussey

  • Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island

    Jerome Viala;Catherine Chaput;Ivo G Boneca;Ana Cardona

  • The NLR gene family: a standard nomenclature

    Jenny P.Y. Ting;Ruth C. Lovering;Emad S. Alnemri;John Bertin

  • Nod-like proteins in immunity, inflammation and disease.

    Jorg H Fritz;Richard Louis Ferrero;D J Philpott;Stephen E Girardin

  • Bacterial infection causes stress-induced memory dysfunction in mice

    Mélanie G Gareau;Eytan Wine;Eytan Wine;David M Rodrigues;Joon Ho Cho

  • Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2.

    Stephen E. Girardin;Leonardo H. Travassos;Mireille Hervé;Didier Blanot

  • Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity.

    Unknown

  • CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri

    Stephen E. Girardin;Régis Tournebize;Maria Mavris;Anne Laure Page

  • NOD proteins: regulators of inflammation in health and disease

    Dana J. Philpott;Matthew T. Sorbara;Susan J. Robertson;Kenneth Croitoru

  • Recognition of Staphylococcus aureus by the Innate Immune System

    Bénédicte Fournier;Dana J. Philpott

  • Modulating immunity as a therapy for bacterial infections.

    Robert E. W. Hancock;Anastasia Nijnik;Dana J. Philpott

  • Toll‐like receptor 2‐dependent bacterial sensing does not occur via peptidoglycan recognition

    Leonardo H Travassos;Leonardo H Travassos;Stephen E Girardin;Dana J Philpott;Didier Blanot

  • Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells

    Maria Kaparakis;Lynne Turnbull;Leticia Carneiro;Stephen Firth

  • Gut Microbial Metabolism Drives Transformation of Msh2-Deficient Colon Epithelial Cells

    Antoaneta Belcheva;Thergiory Irrazabal;Susan J. Robertson;Catherine Streutker

  • Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.

    Jörg H. Fritz;Stephen E. Girardin;Catherine Fitting;Catherine Werts

  • Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation.

    Mathias Chamaillard;Stephen E. Girardin;Jérôme Viala;Dana J. Philpott

  • NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-κB and JNK pathways by inducing reactive oxygen species production

    Ivan Tattoli;Leticia A Carneiro;Muguette Jéhanno;Joao G Magalhaes

  • A critical role for peptidoglycan N-deacetylation in Listeria evasion from the host innate immune system

    Ivo G. Boneca;Olivier Dussurget;Didier Cabanes;Marie-Anne Nahori

  • Conversion of PtdIns(4,5)P2 into PtdIns(5)P by the S.flexneri effector IpgD reorganizes host cell morphology

    Kirsten Niebuhr;Sylvie Giuriato;Thierry Pedron;Dana J. Philpott

Frequent Co-Authors

Stephen E. Girardin
Stephen E. Girardin University of Toronto
Richard L. Ferrero
Richard L. Ferrero Hudson Institute of Medical Research
Philippe J. Sansonetti
Philippe J. Sansonetti Institut Pasteur
Ivo G. Boneca
Ivo G. Boneca Institut Pasteur
Damien Arnoult
Damien Arnoult Grenoble Alpes University
Philip M. Sherman
Philip M. Sherman University of Toronto
John Bertin
John Bertin GlaxoSmithKline (United Kingdom)
Michael Glogauer
Michael Glogauer University of Toronto
Anne M. Griffiths
Anne M. Griffiths University of Toronto
Amira Klip
Amira Klip University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in Immunology often intersects with various healthcare fields, especially nursing. For those interested in advancing their qualifications, exploring the doctorate in nursing salary gives valuable insight into the financial benefits of earning a Doctor of Nursing Practice (DNP) degree. This advanced qualification can significantly enhance job prospects and earning potential.

Many Immunology professionals transition into specialized roles such as acute care. Obtaining an acute care nurse practitioner certification is a crucial step for nurses looking to expand their clinical expertise in fast-paced, high-stakes environments. This certification opens doors to working with critically ill patients, a setting closely related to immunological disorders.

For those already holding a Registered Nurse license, accelerated pathways like the accelerated rn to np programs offer a faster route to becoming a Nurse Practitioner (NP). These programs are designed to build on previous nursing experience, making them ideal for career advancement within related fields.

Beginners without a nursing background can start their journey with online rn programs for non nurses in florida or similar programs nationwide. These online programs provide flexible, accessible education, paving the way to enter healthcare and eventually specialize in areas like Immunology.

Best Scientists Citing Dana J. Philpott

Trending Scientists

Recently Published Articles